By Life Scientist Staff  – Wednesday, 04 May, 2016 Regenerative medicine company Orthocell (ASX:OCC) has been granted ethical approval by St Vincent’s Hospital Melbourne for a clinical study using its Celgro SMRT Grant collagen scaffold. Set to begin in the second quarter of 2016, the primary objective of the 25-patient study is to demonstrate the safety […]